• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Cybersecurity Challenges Leave Medical Device Makers Insecure

    OEMs Are Demanding Designs that Challenge Suppliers

    Diabetes Technology Manufacturers Seemingly on a Sugar Rush

    Post-Pandemic Partnerships: A Full-Service Outsourcing Discussion

    Discovering the Value of Surface Treatments and Coatings for Medtech
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    OmniGuide's RevoLix HTL Hybrid Thulium Laser OK'ed for BPH and Stone Treatments

    In Vitro Diagnostic Medical Devices Regulation Takes Effect

    Brian Case Appointed Chief Technology Officer at KORU Medical

    Solid Growth Expected for India's Medical Device Sector

    Hologic Gains CE Mark for 2 Molecular Assays for Transplant Patients
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Cybersecurity Challenges Leave Medical Device Makers Insecure

    OEMs Are Demanding Designs that Challenge Suppliers

    Diabetes Technology Manufacturers Seemingly on a Sugar Rush

    Post-Pandemic Partnerships: A Full-Service Outsourcing Discussion

    Discovering the Value of Surface Treatments and Coatings for Medtech
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Injecting Neurostimulators into Blood Vessels (We Swear, It’s Not Sci-Fi)

    Understanding the Costs of Care in the OR

    Sick of Being Sick: Pandemic Fatigue Flares at AAOS

    Managing Critical Healthcare Supply Chains in Turbulent Times

    To Drive Value, Human Capital Leaders Turn to Outsourced Solutions
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Trademark Plastics Inc.

    Xact Wire EDM Corp.

    Cirtec Medical

    Arthur G. Russell Co. Inc., The

    Concise Engineering
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    3D Printing in Dental Prosthodontics, Orthodontics, and Surgery

    What New Tech Can Improve Your Medical Manufacturing Plant?

    Why Medical Device Firms Must Navigate the Muddy Waters of ESG Requirements

    Medical Device Servicing vs. Remanufacturing

    Digital Marketplaces for Medical Equipment Come of Age
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Trademark Plastics Inc.

    Xact Wire EDM Corp.

    Cirtec Medical

    Arthur G. Russell Co. Inc., The

    Concise Engineering
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Top30

    12. Danaher

    ...

    12. Danaher
    Related CONTENT
    • The 2019 Top 30 Global Medical Device Companies
    • Catching Its Breath: Observations from the 2019 Top Companies Reports
    • The 2019 Top 30 Global Medical Device Companies
    • 2. Johnson & Johnson
    • 3. GE Healthcare
    07.30.19
    AT A GLANCE
    Rank: #12 (Last year: #13)
    $9.10 Billion ($19.9B total)
    Prior Fiscal: $8.60 Billion
    Percentage Change: +5.81%
    No. of Employees: 71,000 (total)
    Global Headquarters: Washington, D.C.

    KEY EXECUTIVES
    Thomas P. Joyce Jr., President and CEO
    Matthew R. McGrew, Exec. VP and CFO
    Brian W. Ellis, Sr. VP and General Counsel
    William H. King, Sr. VP, Strategic Development
    Robert S. Lutz, Sr. VP and Chief Accounting Officer
    Daniel A. Raskas, Sr. VP, Corporate Development
    Chris Riley, President, Beckman Coulter Diagnostics
    Matt Turner, President, Ormco
    Christophe Duret, President, HemoCue
    Markus Lusser, President, Leica Microsystems
    Susan Murphy, President, Molecular Devices
    Jennifer Honeycutt, President, Pall
    Inese Lowenstein, President, SCIEX
    Hans Geiselhöringer, President, Nobel Biocare

    Westslope cutthroats run big in the South Fork. So do bull trout, which can grow as large as 25 pounds from a steady diet of scuds, minnows, mayflies (depending on river currents), kokanee (a.k.a., sockeye) salmon, and, ironically enough, cutthroats.

    Trout bite all year long in the South Fork. Big Sky biologists say the river contains 400 to 1,000 fish per mile, with cutthroats ranging from 12 to 18 inches and bulls averaging more than 20 inches (some can reportedly reach two and a half feet!). It’s not unusual to find larger-than-normal fish in this part of North America, as the cool, nutrient-rich water flow from mountain streams creates an ideal breeding ground for trout prey. These food factories are often so prolific that trout can get bigger simply by staying in one spot and feeding on their surroundings.

    The 98-mile South Fork of western Montana’s majestic Flathead River begins deep within the Bob Marshall Wilderness Complex, a 1.53 million-acre tract of Congressionally-designated wild land flanking the Continental Divide. The South Fork begins at the junction of Danaher and Young’s creeks; fed by dozens of small tributaries, it runs for 45 miles due north before exiting The Bob near Spotted Bear Ranger Station.

    South Fork is the site of the world’s highest morning glory spillway (water cascades 490 feet off the 66-year-old Hungry Horse Dam). It’s also the site of inspiration for Steven and Mitchell Rales’ entrepreneurial aspirations: During an early 1980s fishing trip on the river, the Bethesda, Md., brothers envisioned starting a new kind of manufacturing company—an entity committed to continuous improvement and customer satisfaction. Using their favorite fishing spot as a muse, the Rales decided their organization would operate much like the South Fork: continuously moving forward but able to quickly change flow.

    The Rales’ new company began as a real estate investment trust but assumed its true mission after refocusing on manufacturing and adopting kaizen, the Japanese business philosophy of continuous improvement. In a nod to their muse, the brothers renamed the firm Danaher (quite appropriate, considering “dana” actually is an ancient Celtic word for “swift-flowing”).

    Danaher spent its formative years as a group of individual manufacturing businesses. Over the past quarter century, however, the Rales have become renowned for their unique approach to business growth; the strategy involved buying other companies’ discards and subjecting them to the Danaher Business System (a set of lean manufacturing and continuous improvement principles) to raise their margins and capital returns. That method has worked rather well for the company in its evolution into a multi-billion-dollar conglomerate with operations in life sciences, diagnostics, dental, environmental services, and industrial tools.

    “We have never strayed from the clarity of our intention or the inspiration of that swift-flowing river,” the company states in a brief autobiography on its home page. “We adapt quickly to the changing flow of business and the evolution of technology, but our guiding principles—continuous improvement and customer satisfaction—remain rock solid.”

    Those guiding principles, though, have largely dictated Danaher’s ever-changing business flow throughout its lifetime. Case in point: The company entered the medtech industry in the early part of the millennium to offset saturation and low growth rates in its capital-intensive and cyclical industrial platform. Upon diversifying its healthcare offerings (through acquisition), Danaher spun off its industrial businesses into an independent, publicly-traded firm (Fortive) focusing on professional instrumentation, automation, sensing, and transportation technologies.

    The Fortive spinoff turned Danaher into a predominantly healthcare-focused business with offerings in acute care, pathology diagnostics, life sciences instrumentation, and dental technology. The split also has created significant shareholder value for both companies—since the July 2016 breakup, Fortive and Danaher have provided total returns of nearly 70 percent and 61 percent, respectively, (through February this year).

    Sales and profits have benefitted from the spinoff as well: Fortive’s 2018 revenue grew 12 percent to $6.45 billion, and profits swelled 3.1 percent to $1.17 billion. First-quarter sales this year jumped 6.7 percent, with core revenues rising 3.7 percent. Danaher’s finances experienced a similar boost, with fiscal 2018 sales climbing 8.5 percent to $19.89 billion and profits surging 13.8 percent to $3.4 billion, according to the company’s 2018 annual report. First-quarter 2019 sales rose 3.9 percent and gross profit advanced 2.8 percent to $2.71 billion.

    The Rales brothers are hoping history repeats itself with the spinout of Danaher’s dental segment, announced last July. The dental unit has been a monetary millstone for the company in recent years due to inventory restocks and product manufacturing/distribution realignments. Dental segment revenue has barely moved since fiscal 2016, edging up only $59.1 million to $2.84 billion through Dec. 31, 2018. Operating profit, meanwhile, has nosedived, falling 4.4 percent in 2017 (to $400.7 million) and a staggering 13.5 percent last year to $346.7 million.

    “The dental unit has been a sore spot for Danaher amid otherwise strong organic growth and profitability,” Bloomberg opinion columnist Brooke Sutherland wrote upon learning of the spinoff. “Talking about and trying to fix that business sucked up an increasing amount of executives’ time. And while there are signs that efforts to cut costs and invest in new growth initiatives at the dental unit are yielding results, the turnaround efforts had undoubtedly become a distraction and both companies should be better off as separate entities.”

    Danaher executives agree. Commenting on the spinoff last summer, Danaher president/CEO Thomas Joyce Jr. predicted the move would cultivate more focused, savvy investments that eventually will boost long-term shareholder value for both companies.


    ANALYST INSIGHTS: Danaher is a company very adept at portfolio management. Watch for them to continue that focus with incremental M&A activities. Don’t be surprised if it decides to either make a large opportunistic acquisition or divest one of its current businesses or both. It’s a rare year when Danaher stands still.

    —Dave Sheppard, Co-Founder and Managing Advisor, MedWorld Advisors



    “This is an important step towards realizing even greater potential for both Danaher and our Dental business,” Joyce said. “[The] announcement demonstrates our commitment to maximizing long-term value for all of our shareholders, customers, and associates. We believe that our Dental business can be more effective as a standalone company, with greater focus around both organic and inorganic investment opportunities.”

    Danaher’s DentalCo (a new name is forthcoming) is expected to be completely free of its parent firm in the second half of 2019. The company will be tax free to shareholders and comprise the KaVo Kerr, Nobel Biocare, and Ormco businesses. It will employ 12,000 workers and be led by president/group executive Amir Aghdaei.

    DentalCo’s diverse product offerings should help the firm succeed upon its independence. All three business divisions debuted new innovations last year, beginning with the winter premiere of KaVo Kerr’s flexible digital intraoral X-ray sensor (DEXIS FS Ergo), X Pro intraoral scanner, and Dex Voice.

    Danaher branded the FS Ergo as a “new category” of intraoral sensors designed to improve patient comfort and diagnostic detail. The Dex Voice, unveiled at the 2018 Chicago Midwinter dental meeting, is built on the Amazon Echo/Alexa platform and fully integrates with the company’s Dexis software. Its smart speaker enables clinicians to deliver voice commands to Alexa to perform Dexis actions that normally would require keyboard or other manually entered commands.

    Over the summer, KaVo Kerr introduced a handheld X-ray system (the NOMAD Pro 2), cross-cut carbide burrs, a titanium sensor featuring motion detection capabilities, and a composite system (SonicFill 3) designed to fill cavities in seconds. The SonicFill 3 SingleFill system contains a nanoscale zirconsil (zirconium oxide plus silica oxide) composite filler, which provides effective blending, wear resistance, strength, and reliability for lasting restorations, according to Danaher.

    Nobel Biocare timed its only product launch for the summer as well, releasing to market a two-piece ceramic implant featuring a cement-free connection to support natural soft tissue appearance. Made of zirconia, the NobelPearl is designed to encourage excellent soft tissue attachment and minimize inflammation. The product is particularly useful in thin gingival biotype cases.

    Ormco debuted the bulk of its new technologies last spring and fall, including a ceramic twin bracket system, a self-litigating bracket (with twice the rotational control and more space under the tie-wing than its predecessor), and a line of stainless-steel instruments (45 pliers, 12 cutters).

    “We are building a better, stronger Danaher,” Joyce wrote in his annual shareholder letter last year. “With the Danaher Business System as our driving force, we strengthened our footholds in attractive, fast-growing markets and enhanced our competitive positions. We accelerated our core revenue growth rate, led primarily by the impact of new product innovation and sales and marketing initiatives. Financially and strategically, 2018 was an outstanding year.”

    Indeed, it was—for Danaher’s non-dental business segments. Sales in the company’s Life Sciences, Diagnostics, and Environmental & Applied Solutions units posted solid gains, rising 13.3 percent, 7.1 percent, and 8.8 percent, respectively.

    Diagnostics revenue, which totaled $6.25 billion, was fueled by strong growth in each product division. Molecular diagnostics, for example, experienced robust infectious disease commodity sales upon the outbreak of a severe flu season last winter as well as the additions of new assays to its portfolio. The unit’s Cepheid business won U.S. Food and Drug Administration (FDA) approval for rapid flu A/B, Strep A, and carbapenem non-susceptible bacteria tests, and CE IVD marking for Hepatitis B and Hepatitis C tests.

    Acute Care Diagnostics profited from strong sales of blood gas and immunoassay products across most major geographies, while new innovations in advanced staining and core histology bolstered Pathology Diagnostics sales.

    Clinical Lab Diagnostics proceeds rose on higher 2018 sales in China and stronger demand for immunoassay products. The business met that demand in part last year by commercializing solutions like Access Sensitive Estradiol, a test for measuring estradiol levels in blood (for diagnosing fertility, menstruation, or puberty problems).

    The E2 (estradiol) test was just one of a number of products the Clinical Lab Diagnostics business marketed last year (through Danaher’s Beckman Coulter Diagnostics arm). Other commercialized innovations included:
    • DxM 6100 Autoplak Advanced automated plate streaking system, a fully contained automated solution for boosting lab productivity, workflow, flexibility, and testing quality. The DxM 6100 automates and integrates core aspects of microbiology specimen processing, including plating and streaking, Gram stain slide preparation and enrichment broth inoculation. The solution streamlines routine tasks and helps laboratories manage increasing testing volumes by enabling them to reallocate technical resources as needed.
    • DxM MicroScan WalkAway system, a diagnostic solution for bacterial identification and antibiotic susceptibility testing that uses direct minimum inhibitory concentrations for antimicrobial resistance detection. Added workflow enhancements include a new fluid-level sensing technology, external LED indicators that show status at a glance, quick bottle release for simplifying reagent maintenance, and integrated reliability improvements to maximize uptime.
    • DxONE PROService, a custom remote service application that helps labs achieve fast turnaround times for patient test results through continuous instrument monitoring. The PROService allows Beckman Coulter to work in collaboration with labs to identify potential system issues with alerts for possible workflow disruptions.
    • DxH 900 hematology analyzer,  a device that gives mid- to high-volume clinical labs the ability to perform complete blood count and white blood cell differential tests with minimal repeats. Its core technologies—an enhanced Coulter Principle, VCS 360, and DataFusion—offer high-resolution analysis of cells in their near-native states, providing a precise cellular assessment for red blood cell, platelet, and white blood cell test results on the first pass.
    In addition to commercialization efforts, Beckman Coulter secured CE mark approval for its Early Sepsis Indicator and DxH 520 Hematology analyzer. The Early Sepsis Indicator identifies patients who either have developed sepsis or are at risk of developing it. It is the first early sepsis warning test to be offered as part of a complete blood count with differential, according to the company. 

    The 520 Hematology analyzer is made to enhance doctor office laboratory efficiency and resource management through the automation of daily tasks. Using two aqueous-based cyanide-, azide- and formaldehyde-free reagents, the system reduces the amount of time spent on lab operations and frees up time for patient care.

    Two months after receiving the CE mark for the 520 Hematology analyzer Beckman Coulter scored a double regulatory victory in June 2018 with back-to-back clearances in Canada and the United States for its high-sensitivity troponin (hsTnl) assay, Access hsTn1, a test for detecting troponin l—a protein present in circulation during myocardial infarction. The FDA cleared the assay for use on the Access 2, DxI, and the entire Access family of immunoassay systems.
    Related Searches
    • diagnostic
    • assessment
    • blood
    • investment
    Suggested For You
    The 2019 Top 30 Global Medical Device Companies The 2019 Top 30 Global Medical Device Companies
    Catching Its Breath: Observations from the 2019 Top Companies Reports Catching Its Breath: Observations from the 2019 Top Companies Reports
    The 2019 Top 30 Global Medical Device Companies The 2019 Top 30 Global Medical Device Companies
    2. Johnson & Johnson 2. Johnson & Johnson
    3. GE Healthcare 3. GE Healthcare
    18. 3M Health Care 18. 3M Health Care
    22. Dentsply Sirona 22. Dentsply Sirona
    23. Canon Medical Systems 23. Canon Medical Systems
    27. Hologic 27. Hologic
    29. Hillrom 29. Hillrom
    Bentec Medical Appoints New CEO Bentec Medical Appoints New CEO
    Beckman Coulter Introduces Total Laboratory Automation Solution Beckman Coulter Introduces Total Laboratory Automation Solution
    Beckman Coulter Beckman Coulter's Blood Test Analyzers Recalled Over Risk of Inaccurate Platelet Analyzing Results
    FDA OKs Beckman Coulter FDA OKs Beckman Coulter's Early Sepsis Indicator
    FDA Clears Beckman Coulter FDA Clears Beckman Coulter's Compact, Low-Volume Hematology Analyzer

    Related Content

    • The 2019 Top 30 Global Medical Device Companies

      The 2019 Top 30 Global Medical Device Companies

      The lack of a significant megamerger in 2018 stood out in an industry that had become accustomed to annual blockbuster deals.
      Sean Fenske, Michael Barbella, & Sam Brusco, MPO Editorial Staff 07.30.19

    • Catching Its Breath: Observations from the 2019 Top Companies Reports

      Catching Its Breath: Observations from the 2019 Top Companies Reports

      ...
      Sean Fenske, Editor-in-Chief 07.30.19

    • The 2019 Top 30 Global Medical Device Companies

      The 2019 Top 30 Global Medical Device Companies

      ...
      Sean Fenske, Michael Barbella, & Sam Brusco, MPO Editorial Staff 07.30.19


    • 2. Johnson & Johnson

      2. Johnson & Johnson

      ...
      07.30.19

    • 3. GE Healthcare

      3. GE Healthcare

      ...
      07.30.19


      Trending
      • Dexcom Reportedly In Talks To Acquire Insulet | Medical Product Outsourcing
      • Shrinking Medical Devices Create Sizable Challenges For Micromolders | Medical Product Outsourcing
      • 5 Ways Plastics Revolutionized The Healthcare Industry | Medical Product Outsourcing
      • Anumana's ECG Pulmonary Hypertension AI Algorithm Gains Breakthrough Status | Medical Product Outsourcing
      • Prometheus Group Sued Over Reused Catheters And Rectal Sensors | Medical Product Outsourcing
      Breaking News
      • Medtronic, DaVita to Create New Kidney Care Firm
      • OmniGuide's RevoLix HTL Hybrid Thulium Laser OK'ed for BPH and Stone Treatments
      • In Vitro Diagnostic Medical Devices Regulation Takes Effect
      • Brian Case Appointed Chief Technology Officer at KORU Medical
      • Solid Growth Expected for India's Medical Device Sector
      View Breaking News >
      CURRENT ISSUE

      May 2022

      • Cybersecurity Challenges Leave Medical Device Makers Insecure
      • Contract Design for Medtech
      • Diabetes Medical Device Technology Update
      • Medtech Full-Service Outsourcing Q&A 2022

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Thorne Relaunches Gut Health Test with Microbiome Wipe
      Alkemist Labs Announces Alkemist Assured Seal and Next Generation Transparency Reports
      GC Rieber Foundations Expand Philanthropic Efforts
      Coatings World

      Latest Breaking News From Coatings World

      ICP Receives ASC Innovation Award for Spray Foam That Meets Changing Environmental Regulations
      Pylon Coatings Uses Polygiene Biomaster & Verimaster for Antimicrobial Surface Protection
      Sto Corp. Recognized with Multiple Honors at the EIFS Hero Awards
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      OmniGuide's RevoLix HTL Hybrid Thulium Laser OK'ed for BPH and Stone Treatments
      In Vitro Diagnostic Medical Devices Regulation Takes Effect
      Brian Case Appointed Chief Technology Officer at KORU Medical
      Contract Pharma

      Latest Breaking News From Contract Pharma

      DFE Pharma Opens India CoE for Fast-Track Formulation Services
      Helsinn Establishes New R&D Hub in the U.S.
      CureVac, myNEO Partner on Antigen Targets for mRNA-Cancer Vax Development
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      Carlyle To Acquire HCP Packaging
      Estée Lauder Companies Faces Class Action Lawsuit
      La Roche-Posay Launches Matte Moisturizer for Oily Skin
      Happi

      Latest Breaking News From Happi

      Women in Flavor and Fragrance Present 2022 Recognition Awards Dinner June 16
      Univar Expands Distribution Agreement with ANGUS Chemical Company
      Acme-Hardesty Passes Responsible Distribution Verification
      Ink World

      Latest Breaking News From Ink World

      NAPIM’s Virtual Digital & Emerging Technologies Conference is Back, June 14–15, 2022
      CEMATEX Introduces Online Business Platform to Connect Global Textile Community
      PICO Chemical Celebrates 46 Years
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      Teklynx software helps Top Clean Injection validate labels
      Zeller+Gmelin named Berry Global’s 2021 Ink Supplier of the Year
      Videojet and Loftware partner to accelerate labeling automation
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Rael Raises $35M in Series B Funding
      Schobertechnologies Offers Rotary Web-fed Converting Solutions
      Thorne Relaunches Gut Health Test with Microbiome Wipe
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      ManaMed's ManaSport Wearable Ultrasound Earns FDA Nod
      Ekso Bionics Names Jerome Wong as Interim CFO
      Exactech Completes First Surgeries Using Next-Gen Cage Glenoid
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      ams OSRAM Introduces New Horticulture LEDs
      Avery Dennison Launches AD Twist U7XM Inlays
      ARPA-E Funding Drives Innovation, Industry Partnerships at NREL

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login